Does Nirma want to be a pharma company?
Finshots Daily
00:00
Nirma's Story: From a Washing Pot of Brand to a Cement Giant
Nirma has bought Glenmark life sciences. Glenmarks made quite a name for itself in the active pharmaceutical ingredient space Or API business. India is heavily dependent on China for APIs We import 70-80% of our requirements And the government wants domestic Fama to get into the API game fully. If Nirma gets its hands on Glenmark's API business it could finally realise its Fama ambitions. It might be able to snag these incentives and bring down the prices of drugs too.
Play episode from 04:53
Transcript
